Although the sarcoma breakdown list was not provided in that study, from the analytical result that MDM2, TP53, and RB1 were discriminative genes, one can expect that a significant portion of the dataset comprised liposarcoma and complex karyotype sarcomas such as leiomyosarcoma and osteosarcoma, which are currently not subjects of targeted therapy. The gene discussed is MDM2; the disease is sarcoma.